Beyond The Headlines

1. Prelude Therapeutics And Lilly Agree To Supply Drugs For Combination Trial 10/15/2026

   Prelude Therapeutics and Lilly agree to supply two medicines for a Phase 1 breast cancer trial, highlighting coordination needs as the study advances to combination cohorts.

2. Lonza Expands DNA-To-IND Pathway For Complex Biologics 10/14/2026

   Lonza expands its accelerated DNA-to-IND pathway to complex biologics, targeting IND readiness in as little as six months and raising clinical supply planning considerations.

3. FedEx Europe Launches Digital Portal For Temperature-Controlled Pharmaceutical Shipments 10/13/2026

   FedEx launches a digital booking portal across 26 European markets for temperature-controlled pharmaceutical shipments, packaging orders, scheduling, and returns.

4. Andelyn Biosciences And PQP Group Establish EU And UK Supply Pathway For Cell And Gene Therapies 10/9/2026

   Andelyn Biosciences and PQP Group partner to coordinate import, QP certification, and distribution for cell and gene therapies entering European clinical supply markets.

5. FDA Transparency Roadmap Could Give Clinical Supply Teams More Visibility 10/7/2026

   FDA transparency efforts could give clinical supply teams more insight into regulatory and inspection risks that may affect manufacturing, inventory and distribution.

6. NIHR Centre Creates New IMP Transfer Process With Potential To Scale Across UK 10/6/2026

   NIHR establishes a governed IMP transfer process between clinical trial sites, creating a potential new approach to managing site-level inventory, demand and clinical supply.